![Scott N. Cullison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott N. Cullison
Corporate Officer/Principal bei
XENETIC BIOSCIENCES, INC.
Profil
Mr. Scott N.
Cullison is a Vice President-Business Development at Xenetic Biosciences, Inc. Mr. Cullison was previously employed as a VP-Commercial Planning & Program Management by Bellicum Pharmaceuticals, Inc., a Vice President-Business Development by Targacept, Inc., and a VP-Business Development & Commercial Planning by Peloton Therapeutics, Inc. He received his undergraduate degree from the University of Arizona and an MBA from Wake Forest University.
Aktive Positionen von Scott N. Cullison
| Unternehmen | Position | Beginn |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Scott N. Cullison
| Unternehmen | Position | Ende |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2018 |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Corporate Officer/Principal | - |
Ausbildung von Scott N. Cullison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Wählen Sie MarketScreener 
